Joseph Monahan, Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS), sold 25,340 shares at $22.31 ($551K) on 2021-06-02, disclosed to the SEC on 2021-06-02.
Open-market sale of $551k ACRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.50 | 18,240 | $392K | 71.2% |
| 2 | $22.31 | 3,550 | $79K | 14.4% |
| 3 | $22.31 | 3,550 | $79K | 14.4% |
| Total | $21.73 avg | 25,340 | $551K | 100% |
| Filing → |
| ACRS | SELL | 2023-06-22 | $123K | — | Filing → |
| ACRS | SELL | 2023-03-03 | $588K | — | Filing → |
| ACRS | SELL | 2023-02-17 | $65K | — | Filing → |